AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

New rheumatoid arthritis drug. (Musculoskeletal Disorders).

OB GYN News

| February 01, 2002 | Kubetin, Sally Koch | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Anakinra, the third biologic therapy to be approved for moderate to severely active rheumatoid arthritis, may have some therapeutic advantages over its competition.

Anakinra (Kineret) is the first interleukin-1 inhibitor to be approved for the indication. Like the two tumor necrosis factor (TNF)-[alpha] inhibitors, etanercept (Enbrel) and infliximab (Remicade), anakinra is not approved as a first-line therapy but is reserved for patients who have failed to respond to other disease-modifying antirheumatic drugs. Methotrexate remains the mainstay of rheumatoid arthritis therapy, and all three biologic drugs can be used in combination with methotrexate. Etanercept and anakinra also can be used as monotherapies.

...

Related articles from newspapers, magazines, journals, and more
Anakinra Gets FDA's Okay For Rheumatoid Arthritis. (Interleukin-1...
Magazine article from: Family Practice News Bates, Betsy December 15, 2001 700+ words
SAN FRANCISCO -- Anakinra, the third biologic...moderate to severely active rheumatoid arthritis, may prove to have...Administration's approval of anakinra (Kineret) coincided...about the product. Anakinra is the first interleukin...
Anakinra is effective for the treatment of patients with active rheumatoid...
Magazine article from: Inpharma Weekly Anonymous October 18, 2008 700+ words
Anakinra is effective for the treatment of patients with active rheumatoid arthritis (RA), according to researchers...Karanikolas G, et al. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or...
Pharmacology Update: Anakinra Injection (Kineret-Amgen).
Magazine article from: Internal Medicine Alert February 28, 2002 700+ words
Anakinra Injection (KineretAmgen...PhD The FDA has approved anakinra, a recombinant interleukin...for the treatment of rheumatoid arthritis (RA). The drug, which...antirheumatic drugs (DMARDs). Anakinra is a competitive inhibitor...
AMERICAN COLLEGE OF RHEUMATOLOGY AMGEN PRESENTS ADDITIONAL DATA SUPPORTING...
Magazine article from: BIOWORLD Today Huggett, Brady October 31, 2000 700+ words
...presented studies on anakinra, its interleukin...quality of life for rheumatoid arthritis sufferers. In a double...treatment with one of the anakinra doses. Based on radiographs...regulatory approval of anakinra in the United States...effectiveness of its rheumatoid arthritis ...
Anakinra shows promise in adult-onset still disease.(Across Specialties)
Magazine article from: Skin & Allergy News Walsh, Nancy September 1, 2007 700+ words
...Still disease treated with anakinra, Dr. John M. Esdaile said...was less successful than in rheumatoid arthritis and ankylosing spondylitis...IL-1 receptor antagonist anakinra has shown dramatic effects...first injection of 100 mg anakinra. Marked defervescence occurred...
Anakinra's benefits called striking for NOMID.(Neonatal-onset multisystem...
Magazine article from: Skin & Allergy News Jancin, Bruce November 1, 2005 700+ words
...prevented with early anakinra, although, of course...because it identifies anakinra, a drug approved for the treatment of rheumatoid arthritis, as the first highly...1 mg/kg per day of anakinra by daily subcutaneous...
Anakinra to treat patients with neonatal onset multisystem inflammatory...
Magazine article from: Journal of Drugs in Dermatology May 1, 2004 700+ words
...safety and effectiveness of anakinra (Kineret[R]) for treating...cause harmful side effects. Anakinra, approved by The Food and...Administration for treating rheumatoid arthritis in adults, blocks a substance...system malformations Drug: anakinra Phase II Arthropathy, neurogenic...
Interleukin-1 blocker reduces joint erosion and space narrowing, study...
Newspaper article from: Immunotherapy Weekly November 27, 2002 700+ words
...progression in rheumatoid arthritis (RA). Data from...ability of Kineret (anakinra) to inhibit bone...patients with juvenile rheumatoid arthritis (JRA) were announced...patients. Juvenile rheumatoid arthritis study: A 16...
For more facts and information, see all results

Source: HighBeam Research, New rheumatoid arthritis drug. (Musculoskeletal Disorders).

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA